| Description |
1 online resource |
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Prologue: big scandals, higher prices. Pharma under Fire ; A note before we begin ; The strange economics of pharmaceuticals ; Generics, a brief primer -- Introduction: the winding road to generic entry -- "Generation 1.0": the rise and fall of traditional pay-for-delay. The basic contours of pay-for-delay ; Pay-for-delay as a bottleneck to entry ; Is pay-for-delay actually wrong?: pharma heads to the supreme court -- "Generation 2.0": complicating pay-for-delay. Already steps ahead of Actavis ; In re Lipitor: everything but the kitchen sink ; The post-Actavis landscape, contract clauses, and king drug -- "Generation 3.0": new tactics for active obstruction of generics. A new generation of pharmaceutical delay ; product hopping and the purple pill ; New examples of product hopping ; Scout's honor in product hopping |
|
"Generation 3.0": continued obstruction of regulatory pathways. REMS-based delay ; Delay via citizen petition ; Preventing the "skinny label": blocking carve-outs -- Empirical evidence of a citizen's pathway gone astray. Methodology ; Results ; The road ahead -- Conclusion: a call for systematic reform. Societal harms ; Systems, simplification, sunshine, and standards-based doctrines. |
| Summary |
In this book, Feldman and Frondorf explain how companies employ strategies that block generic medicines from the market and keep prices high. |
| Local Note |
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
| Subject |
Drugs -- Prices -- United States.
|
|
Drugs -- Law and legislation -- United States.
|
|
Pharmaceutical policy -- United States.
|
|
Pharmaceutical industry -- United States.
|
|
Generic drugs -- United States.
|
|
Generic drugs.
|
|
Trademarks.
|
|
Pharmaceutical industry.
|
|
United States |
|
trademarks. |
|
BUSINESS & ECONOMICS -- Industries -- General. |
|
Trademarks |
|
Drugs -- Law and legislation |
|
Drugs -- Prices |
|
Generic drugs |
|
Pharmaceutical industry |
|
Pharmaceutical policy |
|
United States https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| Other Form: |
Print version: Feldman, Robin. Drug Wars : How Big Pharma Raises Prices and Keeps Generics off the Market. New York : Cambridge University Press, ©2017 |
| ISBN |
131675300X (electronic bk.) |
|
9781316753002 (electronic bk.) |
|
9781316754931 (electronic bk.) |
|
1316754936 (electronic bk.) |
|
9781316749142 |
|
1316749142 |
|
9781316717424 |
|
1316717429 |
|
1107168481 |
|
9781107168480 (hardback) |
| Standard No. |
13382979 |
|
